Showing 1 - 3 results of 3 for search 'Yoav H. Messinger', query time: 0.03s Refine Results
  1. 1
    Successful reduction of high-sustained anti-idursulfase antibody titers by immune modulation therapy in a patient with severe mucopolysaccharidosis type II

    Successful reduction of high-sustained anti-idursulfase antibody titers by immune modulation therapy in a patient with severe mucopolysaccharidosis type II by Katherine H. Kim, Yoav H. Messinger, Barbara K. Burton

    Published 2015-03-01
    Get full text
    Article
  2. 2
    Healthcare cost and utilization for chimeric antigen receptor (CAR) T‐cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis

    Healthcare cost and utilization for chimeric antigen receptor (CAR) T‐cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims databas... by Alex Hoover, Paige Reimche, Dave Watson, Lynn Tanner, Laura Gilchrist, Mike Finch, Yoav H. Messinger, Lucie M. Turcotte

    Published 2024-02-01
    Get full text
    Article
  3. 3
    STXBP2-R190C Variant in a Patient With Neonatal Hemophagocytic Lymphohistiocytosis (HLH) and G6PD Deficiency Reveals a Critical Role of STXBP2 Domain 2 on Granule Exocytosis

    STXBP2-R190C Variant in a Patient With Neonatal Hemophagocytic Lymphohistiocytosis (HLH) and G6PD Deficiency Reveals a Critical Role of STXBP2 Domain 2 on Granule Exocytosis by Nathalia Benavides, Waldo A. Spessott, Maria L. Sanmillan, Marcelo Vargas, Mylynda S. Livingston, Nissa Erickson, Tamara C. Pozos, Margaret E. McCormick, Emilia Scharrig, Yoav H. Messinger, Claudio G. Giraudo

    Published 2020-10-01
    Get full text
    Article

Search Tools: